Article citationsMore>>

Gauthier, K., Bai, A., Perras, C., et al. (2012) Denosumab, Raloxifene, and Zoledronic Acid for the Treatment of Postmenopausal Osteoporosis: Clinical Effectiveness and Harms. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health.

has been cited by the following article: